June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Binding of αA- and αB-crystallin to the model of human lens lipid membranes
Author Affiliations & Notes
  • Laxman Mainali
    Physics, Boise State University, Boise, Idaho, United States
    Biomolecular Sciences Graduate Program, Boise State University, Boise, Idaho, United States
  • Raju Timsina
    Physics, Boise State University, Boise, Idaho, United States
  • Geraline Trossi-Torres
    Biomolecular Sciences Graduate Program, Boise State University, Boise, Idaho, United States
  • Preston Hazen
    Biomolecular Sciences Graduate Program, Boise State University, Boise, Idaho, United States
  • Nawal K. Khadka
    Physics, Boise State University, Boise, Idaho, United States
  • Footnotes
    Commercial Relationships   Laxman Mainali None; Raju Timsina None; Geraline Trossi-Torres None; Preston Hazen None; Nawal Khadka None
  • Footnotes
    Support  This work was supported by the National Institutes of Health (USA) under Grant R01 EY030067.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4139. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Laxman Mainali, Raju Timsina, Geraline Trossi-Torres, Preston Hazen, Nawal K. Khadka; Binding of αA- and αB-crystallin to the model of human lens lipid membranes. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4139.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : It is well-studied that levels of α-crystallin in the eye lens cytoplasm decrease steadily with increasing membrane-bound α-crystallin with age and cataracts. However, the binding of αA- and αB-crystallin to the eye lens membranes is poorly understood. This study investigates the binding of recombinant human αA- and αB-crystallin to the model of human lens lipid (MHLL) membranes with and without cholesterol (Chol) and measures the physical properties of these membranes.

Methods : The genes for human αA- and αB-crystallin obtained from Genescript USA inc. were expressed recombinantly in E. coli using a pET-43.1a(+) plasmid system. Small unilamellar vesicles of the model of human lens lipid (MHLL) membranes and 33 mol% cholesterol-containing MHLL membranes (Chol/MHLL = 0.5) were prepared using the rapid solvent exchange method and probe-tip sonication. The binding of recombinant human αA- and αB-crystallin to the MHLL and Chol/MHLL = 0.5 membranes and the physical properties of these membranes were measured using the electron paramagnetic resonance spin-labeling method.

Results : The maximum percentage of membrane surface occupied (MMSO) by αA-crystallin on the MHLL membranes is higher compared to αB-crystallin; however, the binding affinity (Ka) of αA-crystallin to the MHLL membranes is lower compared to αB-crystallin. The MMSO by αA- and αB-crystallin on the Chol/MHLL = 0.5 membranes is significantly lower than on the MHLL membranes, implying that Chol significantly decreases the binding of αA- and αB-crystallin to these membranes. The binding of αA- and αB-crystallin to MHLL membranes increases the hydrophobicity near the surface of these membranes, supporting the hypothesis that such binding creates a barrier to ionic and polar molecules. With increased concentrations of αA- and αB-crystallin, the mobility parameters decrease without a significant change in the maximum splittings, suggesting that the HMLL and Chol/MHLL membranes become less mobile without a significant change in the order near their surfaces.

Conclusions : Our results show that αA- and αB-crystallin bind to MHLL and Chol/MHLL membranes differently, altering the physical properties of membranes. Moreover, our results show that Chol substantially decreases the MMSO by αA- and αB-crystallin on the membranes, suggesting that high Chol in the eye lens membranes likely inhibits the binding of α-crystallin to membranes preventing cataract formation.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×